Uno Health, a service aimed at increasing access to benefits and savings for lower-income Americans, has launched the Uno Savings Guide. This free tool helps individuals of all ages, including…
SV Health Investors, a prominent healthcare-focused private equity firm, is excited to announce the promotion of A.J. Rossi to Partner on its Growth-Buyout team. In this role, A.J. will continue…
ClearNote Health, a company dedicated to enhancing early cancer detection, has announced a new partnership with researchers at the University of Southampton’s Clinical Trials Unit in the UK. The team…
Knipper Health, Inc., the leading provider of end-to-end pharmaceutical healthcare marketing services in the U.S. for the biopharmaceutical and medical industries, has announced the acquisition of Patheon Pharma Services’ sample…
Varian, a Siemens Healthineers company, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its RapidArc Dynamic solution. This innovative technology utilizes advanced algorithms to transform…
A new study published in Diabetic Medicine reveals that the standard NHS procedures for processing gestational diabetes blood sugar tests miss over 50% of cases. Gestational diabetes, if undiagnosed or…
Hologic, Inc. (Nasdaq: HOLX) announced today that it has signed an agreement with the Centers for Disease Control and Prevention (CDC) to develop analyte specific reagents (ASRs) — key components…
Hyperfine, Inc. (Nasdaq: HYPR), a pioneering health technology company known for its AI-powered portable MRI brain imaging system, the Swoop® system, has announced further global expansion with new distribution agreements…
Soleo Health, a national leader in complex specialty pharmacy services, today announced the opening of a new ambulatory infusion suite (AIS) in Farragut, Tennessee, just outside of Knoxville, expanding its…
If the word “injection” causes your heart rate to rise, you’re not alone. One in four adults experience a fear of needles, often linked to childhood experiences. Children who frequently…
HeartBeam, Inc. (NASDAQ: BEAT), a company dedicated to revolutionizing cardiac care, has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its HeartBeam system for…
Reprieve Cardiovascular, Inc., a company focused on developing treatments for acute decompensated heart failure (ADHF), announced today the first-in-human results of the Reprieve System at the CSI Focus D-HF (Device…